Your browser doesn't support javascript.
loading
Awareness and Support of Clinician- and Patient-Collected Human Papillomavirus Testing for Cervical Cancer Screening Among Primary Care Clinicians.
MacLaughlin, Kathy L; Jacobson, Robert M; St Sauver, Jennifer L; Jenkins, Gregory D; Fan, Chun; Finney Rutten, Lila J.
Afiliación
  • MacLaughlin KL; Department of Family Medicine, Rochester, Minnesota, USA.
  • Jacobson RM; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, Minnesota, USA.
  • St Sauver JL; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, Minnesota, USA.
  • Jenkins GD; Division of Community Pediatric and Adolescent Medicine, Rochester, Minnesota, USA.
  • Fan C; Department of Quantitative Health Sciences, Rochester, Minnesota, USA.
  • Finney Rutten LJ; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, Minnesota, USA.
Article en En | MEDLINE | ID: mdl-35136872
ABSTRACT

Background:

Cervical cancer screening has shifted toward human papillomavirus (HPV)-based testing, but uptake of primary HPV screening in the United States is unknown and previous studies highlight delays in clinician adoption of guideline updates.

Methods:

We conducted a cross-sectional electronic survey of primary care clinicians (n = 252; response rate = 30.9%) assessing awareness and support of primary HPV screening. We assessed factors for association with past use of HPV testing and support of clinician- and patient-collected HPV testing individually using Fisher's exact test and jointly using Firth's logistic regression.

Results:

Most clinicians (79%) were familiar with one or more primary HPV screening guidelines. Support for clinician-collected (89%) and patient-collected (82%) HPV testing was high, but only 34.5% reported prior use. Guideline familiarity was positively associated with HPV testing in practice (p = 0.0001). Support of clinician-collected testing was positively associated with more years in practice (p = 0.03), internal (vs. family) medicine specialty (p = 0.03), and guideline familiarity (p ≤ 0.0001). Male clinicians more frequently supported patient collection for patients overdue for screening (p = 0.013). Physicians more frequently than advanced practice providers (APPs) supported patient collection for screening-adherent women (p = 0.021). Multivariable analysis showed those unfamiliar with guidelines were less likely to have used HPV testing [odds ratio, OR 0.10 (0.03-0.32)] or to support clinician-collected HPV testing [OR 0.16 (0.07-0.37)]. APPs were less likely than physicians to support patient-collected HPV testing among screening-adherent women [OR 0.42 (0.20-0.87)].

Conclusions:

We observed high levels of guideline awareness and clinician support for primary HPV testing, despite relatively low use. This merits further exploration to inform future interventions to increase uptake.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Qualitative_research / Screening_studies Idioma: En Revista: Womens Health Rep (New Rochelle) Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Qualitative_research / Screening_studies Idioma: En Revista: Womens Health Rep (New Rochelle) Año: 2022 Tipo del documento: Article